Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Add-on Ketamine With Second-dose Midazolam for Prehospital Treatment of Epileptic Children With Status Epilepticus

NCT07095842 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07095842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07095842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Add-on Ketamine With Second-dose Midazolam for Prehospital Treatment of Epileptic Children With Status Epilepticus
Lead sponsor
Sohag University
Phase
Phase 2/3
Overall status
Recruiting
Start date
August 3, 2025
Completion date
August 1, 2026
Enrollment
668 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

convulsive status epilepticus